Panel Discussion

Public-Private Partnerships Healthcare Forum

Synopsis

Bringing together leaders from the public and private sectors in Singapore, as well as domestic and international academic experts, the Healthcare PPP Forum will address the importance of public-private partnerships in healthcare. Speakers will cover two large economic policy issues and implementation issues: elder care and the rise of non-communicable diseases (NCDs) in Singapore and China.

The financing challenge associated with elder care is based on the change in the ratio of workers to retirees. What had been ten workers became five and is now projected to be two per retiree in Singapore, and potentially, China.

NCDs are sweeping both the developed and developing world. The change of diets, lack of exercise and addictive nature of food products has led to an epidemic in obesity. This is impacting GDP growth and productivity globally.

The Forum’s aim is to identify the variety of conditions and applications for PPPs to provide financial and operational solutions to these issues.

The forum is co-sponsored by the National University of Singapore (NUS) Lee Kuan Yew School of Public Policy, the NUS School of Public Health and the PPP Initiative Ltd.

Programme
8.30am: Registration
9.00am: Welcome Remarks by Dr. Phua Kai Hong, Associate Professor of Health Policy & Management, Lee Kuan Yew School of Public Policy, National University of Singapore

9.20am: Panel 1: Healthcare PPPs and Healthcare Economic Policy Impact

Prof. Alan M. Trager, Founder and President of the Public-Private Initiative (Moderator)
Mr. Zee Yoong Kang, Chief Executive Officer (CEO), Health Promotion Board (HPB)
Dr. Chia Kee-Seng, Professor and Former Dean, Saw Swee Hock School of Public Health, National University of Singapore

10.50am: Networking Tea Break

11.05am: Panel 2: Singapore’s Elder Care Economic and Social Challenge - PPP Solutions

Prof. Lim Yee Wei, Associate Professor, Saw Swee Hock School of Public Health, National University of Singapore (Moderator)
Ms. Peh Kim Choo, Chief Executive Officer and Director, Hua Mei Centre for Successful Ageing, Tsao Foundation
Dr. Jason Phua, Chief Executive Officer-Designate of Alexandra Hospital

12.20pm: Questions and Answers by Prof. Alan M. Trager, Founder and President of the Public-Private Initiative
12.50pm: Closing Remarks by Mr. Raphael Ho, General Manager for Singapore, Malaysia and Brunei, Amgen
1.00pm: Networking Lunch

About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit http://www.amgen.com/and follow us on https://twitter.com/amgen